Triclabendazole decreases intracellular cAMP. by Yong Joo Lee (357685)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Decreased fibrin deposition in hypoxic C3−/− mice. by Eileen M. Bauer (337320)

Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers. by Matthias Ringkamp (253465)

“…Kruskal Wallis ANOVA (p<0.01 in both groups) was followed in each group by multiple post-hoc comparisons between mean ranks. Significant differences are indicated as *p<0.05, **p<0.01, ***p<0.001. …”

Over time, melanization decreases with aging, higher temperature, and infection. by Lindsay E. Martin (17377067)

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

UGGT activity decreases in <i>uggt-1(RNAi)</i> worms but no decrease was observed in <i>uggt-2 (RNAi)</i> worms. by Lucila I. Buzzi (198284)

Bone mass and formation are decreased in Akt1-/- mice. by Naohiro Kawamura (33999)

IL-35 decreased the prevalence of Th17 in CD4+ T cells. by Yin Zongyi (3111660)

“…Results are expressed as means ± SEM, from two experiments (n = 3 times/group/experiment). …”

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

“…After adjusting for clinical and demographic variables, significantly decreased BNDF plasma levels were observed in psoriasis patients (P=0.01) (estimated marginal means of 3922 pg/mL; 95%CI=2660-5135) compared with controls (5788 pg/mL; 95%CI=5185-6442). …”

2-ME decreases blood pressure in Sprague Dawley rats. by Weiyu Chen (2216251)

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

PRV-induced infertility is caused by decreased P4 level. by Bing-Qian Su (8616981)

Maternal immune activation mice exhibited impaired social interaction, decreased communication, and repetitive behavior. by Elena Minakova (6195467)

Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

Supplementary Material for: Decreasing Attacks and Improving Quality of Life through a Systematic Management Program for Patients with Hereditary Angioedema by Nunes F.L. (10223465)

“…<b><i>Results:</i></b> Mean number of attacks/month significantly decreased (95% credible interval [CrI] excluding 0) from 1.15 preintervention to 0.25 and 0.23, 8 and 14 months within intervention, with mean decreases of −0.89 (95% CrI: −1.21 to −0.58) and −0.92 (95% CrI: −1.22 to −0.60), respectively. …”

Administration of Tamoxifen decreases PD-induced peritoneal membrane thickness in a mouse model. by Jesús Loureiro (405934)

SGK1 expression is significantly decreased in the prefrontal cortex of PTSD patients. by Pawel Licznerski (82554)

“…For underlying data, see <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1002282#pbio.1002282.s001" target="_blank">S1 Data</a>. NR3C1, glucocorticoid receptor; NR3C2, mineralocorticoid receptor; GMEB1, glucocorticoid modulatory element binding protein 1; GRLF1, glucocorticoid receptor DNA binding factor 1; CRH, corticotropin-releasing hormone; CRHR1, corticotropin-releasing hormone receptor 1; CRHR2, corticotropin-releasing hormone receptor 2; CRHBP, corticotropin-releasing hormone binding protein; UCN, urocortin; UCN3, stresscopin (urocortin 3); FKBP5, FK506 binding protein 5.…”